Furthermore, the quantity of CD34+;αSMA+;CD31+ VECs correlates with clinical outcomes of progressive fibrotic remodeling, offering a novel cellular correlate for the interaction between vascular changes and fibrosis in SSc. This evidence concerns the gene CD34 and systemic sclerosis.